131 related articles for article (PubMed ID: 12015208)
1. Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain.
Garzón J; Rodríguez-Díaz M; López-Fando A; García-España A; Sánchez-Blázquez P
Neuropharmacology; 2002 May; 42(6):813-28. PubMed ID: 12015208
[TBL] [Abstract][Full Text] [Related]
2. Administration of myr(+)-G(i2)alpha subunits prevents acute tolerance (tachyphylaxis) to mu-opioid effects in mice.
Garzón J; Sánchez-Blázquez P
Neuropharmacology; 2001 Mar; 40(4):560-9. PubMed ID: 11249965
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
4. The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects.
Sánchez-Blázquez P; Rodríguez-Díaz M; López-Fando A; Rodríguez-Muñoz M; Garzón J
Neuropharmacology; 2003 Jul; 45(1):82-95. PubMed ID: 12814661
[TBL] [Abstract][Full Text] [Related]
5. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
6. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice.
Suh HH; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):67-71. PubMed ID: 1976234
[TBL] [Abstract][Full Text] [Related]
7. RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance.
Garzón J; Rodríguez-Muñoz M; López-Fando A; García-España A; Sánchez-Blázquez P
Neuropsychopharmacology; 2004 Jun; 29(6):1091-104. PubMed ID: 14997173
[TBL] [Abstract][Full Text] [Related]
8. The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opioid receptors.
Garzón J; López-Fando A; Sánchez-Blázquez P
Neuropsychopharmacology; 2003 Nov; 28(11):1983-90. PubMed ID: 12902995
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
10. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
11. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins.
Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
Neuropsychopharmacology; 2005 Sep; 30(9):1632-48. PubMed ID: 15827571
[TBL] [Abstract][Full Text] [Related]
12. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
13. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
Sánchez-Blázquez P; García-España A; Garzón J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
[TBL] [Abstract][Full Text] [Related]
14. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
15. RGS9 proteins facilitate acute tolerance to mu-opioid effects.
Garzón J; Rodríguez-Díaz M; López-Fando A; Sánchez-Blázquez P
Eur J Neurosci; 2001 Feb; 13(4):801-11. PubMed ID: 11207815
[TBL] [Abstract][Full Text] [Related]
16. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
[TBL] [Abstract][Full Text] [Related]
17. Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments.
Ware TD; Paul D
Eur J Pharmacol; 2000 Feb; 389(2-3):181-5. PubMed ID: 10688982
[TBL] [Abstract][Full Text] [Related]
18. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
20. Calcium/calmodulin-dependent protein kinase II supports morphine antinociceptive tolerance by phosphorylation of glycosylated phosducin-like protein.
Sánchez-Blázquez P; Rodríguez-Muñoz M; Montero C; de la Torre-Madrid E; Garzón J
Neuropharmacology; 2008 Feb; 54(2):319-30. PubMed ID: 18006024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
